Zobrazeno 1 - 10
of 84
pro vyhledávání: '"Maurizio, Puccetti"'
Autor:
Matteo Canale, Elisabetta Petracci, Paola Cravero, Marita Mariotti, Gabriele Minuti, Giulio Metro, Vienna Ludovini, Sara Baglivo, Maurizio Puccetti, Alessandra Dubini, Giovanni Martinelli, Angelo Delmonte, Lucio Crinò, Paola Ulivi
Publikováno v:
Translational Oncology, Vol 23, Iss , Pp 101471- (2022)
Non-small-cell lung cancer (NSCLC) is the primary cause of cancer-related death. Gene rearrangements involving the anaplastic lymphoma kinase (ALK) tyrosine kinase identify a clinical and molecular subset of NSCLC patients, who benefit from the monot
Externí odkaz:
https://doaj.org/article/9fcffe32bbf24565b0725968e3ffe4ea
Autor:
Maria Maddalena Tumedei, Sara Ravaioli, Federica Matteucci, Monica Celli, Ugo De Giorgi, Roberta Gunelli, Maurizio Puccetti, Giovanni Paganelli, Sara Bravaccini
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-7 (2021)
Abstract Bladder cancer (BCa) patients are diagnosed by cytology and cystoscopy. However, these diagnostic tests bear some limitations. We sought for reliable biomarkers to better determine BCa extension. Prostate-specific membrane antigen (PSMA) app
Externí odkaz:
https://doaj.org/article/9e48e4bb4424421c8efc0070bd91a8d6
Autor:
Ivan Vannini, Milena Urbini, Mattia Melloni, Tania Rossi, Giulia Gallerani, Michela Palleschi, Irene Azzali, Maurizio Puccetti, Giovanni Martinelli, Francesco Fabbri
Publikováno v:
Frontiers in Medicine, Vol 9 (2022)
Metaplastic breast cancer (MpBC) is a rare tumor representing 1% of all breast malignancies. The prognosis of this histologic subtype is actually poor and there are no current clear-cut therapeutic guidelines. Hence, despite its uniqueness, its aggre
Externí odkaz:
https://doaj.org/article/740785c21b1b424f876aa70650354903
Autor:
Sara Bravaccini, Giuseppe Bronte, Elisabetta Petracci, Maurizio Puccetti, Manolo D’Arcangelo, Sara Ravaioli, Maria Maddalena Tumedei, Roberta Maltoni, Angelo Delmonte, Federico Cappuzzo, Lucio Crinò
Publikováno v:
Frontiers in Cell and Developmental Biology, Vol 9 (2021)
Programmed death ligand 1 (PD-L1) is an immune checkpoint with a role in cancer-related immune evasion. It is a target for cancer immunotherapy and its expression is detected for the use of some immune checkpoint inhibitors in advanced non-small cell
Externí odkaz:
https://doaj.org/article/db302667216f4985b2e27f223631df39
Autor:
Tania Rossi, Michela Palleschi, Davide Angeli, Michela Tebaldi, Giovanni Martinelli, Ivan Vannini, Maurizio Puccetti, Francesco Limarzi, Roberta Maltoni, Giulia Gallerani, Francesco Fabbri
Publikováno v:
Frontiers in Medicine, Vol 8 (2021)
Circulating tumor cells (CTCs) are a rare population of cells found in the bloodstream and represent key players in the metastatic cascade. Their analysis has proved to provide further core information concerning the tumor. Herein, we aim at investig
Externí odkaz:
https://doaj.org/article/6f8eb4e4161c4b86b5ae70f408d550ad
Autor:
Giuseppe Bronte, Maurizio Puccetti, Elisabetta Petracci, Lorenza Landi, Paola Cravero, Simona Scodes, Paola Ulivi, Sara Ravaioli, Maria Maddalena Tumedei, Marco Angelo Burgio, Federico Cappuzzo, Angelo Delmonte, Lucio Crinò, Sara Bravaccini
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
BackgroundCurrent therapy for non-small-cell lung cancer (NSCLC) frequently includes immune checkpoint inhibitors, such as pembrolizumab, and programmed death ligand 1 (PD-L1) positivity is mandatory for its use in this setting. Vimentin plays a role
Externí odkaz:
https://doaj.org/article/4aab8982f9c94ec6b69779244776a929
Autor:
Alberto Farolfi, Elisabetta Petracci, Luigi Serra, Alessandra Ravaioli, Sara Bravaccini, Sara Ravaioli, Maria Maddalena Tumedei, Paola Ulivi, Matteo Canale, Maurizio Puccetti, Fabio Falcini, Secondo Folli, Annalisa Curcio, Andrea Rocca
Publikováno v:
Frontiers in Oncology, Vol 10 (2020)
Women with a diagnosis of ductal carcinoma in situ (DCIS) have a high risk of developing a second breast event (SBE). The immune system might play a role in trying to prevent a SBE. Patients diagnosed with DCIS were identified in the population-based
Externí odkaz:
https://doaj.org/article/1f1a5cd443a04fe4a584569091a0c592
Autor:
Roberta Maltoni, Michela Palleschi, Sara Ravaioli, Maria Maddalena Tumedei, Andrea Rocca, Elisabetta Melegari, Mattia Altini, Maurizio Puccetti, Silvia Manunta, Sara Bravaccini
Publikováno v:
Cell Transplantation, Vol 29 (2020)
Keup and colleagues provide liquid biopsy preliminary results by sequencing variants in circulating tumor cells (CTCs) and cell-free deoxyribonucleic acid (cfDNA) “all from one tube” format, in order to use the same blood sample under the same is
Externí odkaz:
https://doaj.org/article/cbd36830377747c2addfca4486d1bba4
Autor:
Sara Bravaccini, Giuseppe Bronte, Emanuela Scarpi, Sara Ravaioli, Roberta Maltoni, Anita Mangia, Maria Maddalena Tumedei, Maurizio Puccetti, Patrizia Serra, Lorenzo Gianni, Laura Amaducci, Nicoletta Biglia, Valentina Bounous, Angelo Virgilio Paradiso, Rosella Silvestrini, Dino Amadori, Andrea Rocca
Publikováno v:
Therapeutic Advances in Medical Oncology, Vol 12 (2020)
Background: In the Italian Breast Cancer Intergroup Studies (IBIS) 3 phase III trial, we compared cyclophosphamide, methotrexate, 5-fluorouracil (CMF) alone to sequential epirubicin/CMF regimens in patients with rapidly proliferating early breast can
Externí odkaz:
https://doaj.org/article/9c335358d56743fda946544b114d2f88
Autor:
Giuseppe Bronte, Sara Bravaccini, Sara Ravaioli, Maurizio Puccetti, Emanuela Scarpi, Daniele Andreis, Maria Maddalena Tumedei, Samanta Sarti, Lorenzo Cecconetto, Elisabetta Pietri, Valeria De Simone, Roberta Maltoni, Massimiliano Bonafè, Dino Amadori, Andrea Rocca
Publikováno v:
Translational Oncology, Vol 11, Iss 4, Pp 950-956 (2018)
Genomic studies have shown that the androgen receptor (AR) pathway plays an important role in some breast cancer subtypes. However few data are present on the concordance between AR expression in primary tumors and metastases. We investigated AR expr
Externí odkaz:
https://doaj.org/article/7530afb9d90a49539d950ceec717d50d